Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Preliminary Identification of Coping Profiles Relevant to Surrogate Decision Making in the ICU.

Butler JM, Hirshberg EL, Hopkins RO, Wilson EL, Orme JF, Beesley SJ, Kuttler K, Brown SM.

PLoS One. 2016 Nov 11;11(11):e0166542. doi: 10.1371/journal.pone.0166542. eCollection 2016.

2.

Combinatorial Treatment Effects in a Cell Culture Model of Alzheimer's Disease.

Beesley S, Olcese J, Saunders C, Bienkiewicz EA.

J Alzheimers Dis. 2017;55(3):1155-1166.

PMID:
27814295
3.

Glucose management in the intensive care unit: are we looking for the right sweet spot?

Beesley SJ, Hirshberg EL, Lanspa MJ.

Ann Transl Med. 2016 Sep;4(18):347.

4.

Reply: Let Them In: Family Presence during Intensive Care Unit Procedures.

Beesley SJ, Brown SM.

Ann Am Thorac Soc. 2016 Sep;13(9):1664. doi: 10.1513/AnnalsATS.201606-504LE. No abstract available.

PMID:
27627482
5.

Relative Bradycardia in Patients With Septic Shock Requiring Vasopressor Therapy.

Beesley SJ, Wilson EL, Lanspa MJ, Grissom CK, Shahul S, Talmor D, Brown SM.

Crit Care Med. 2017 Feb;45(2):225-233. doi: 10.1097/CCM.0000000000002065.

PMID:
27618277
6.

Cardiomyocyte Circadian Oscillations Are Cell-Autonomous, Amplified by β-Adrenergic Signaling, and Synchronized in Cardiac Ventricle Tissue.

Beesley S, Noguchi T, Welsh DK.

PLoS One. 2016 Jul 26;11(7):e0159618. doi: 10.1371/journal.pone.0159618. eCollection 2016.

7.

TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer.

James N, Pirrie S, Pope A, Barton D, Andronis L, Goranitis I, Collins S, McLaren D, O'Sullivan J, Parker C, Porfiri E, Staffurth J, Stanley A, Wylie J, Beesley S, Birtle A, Brown J, Chakraborti P, Russell M, Billingham L.

Health Technol Assess. 2016 Jul;20(53):1-288. doi: 10.3310/hta20530.

8.

Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747).

Andronis L, Goranitis I, Pirrie S, Pope A, Barton D, Collins S, Daunton A, McLaren D, O'Sullivan JM, Parker C, Porfiri E, Staffurth J, Stanley A, Wylie J, Beesley S, Birtle A, Brown JE, Chakraborti P, Hussain SA, Russell JM, Billingham LJ, James ND.

BJU Int. 2017 Apr;119(4):522-529. doi: 10.1111/bju.13549. Epub 2016 Jul 10.

PMID:
27256016
9.

Let Them In: Family Presence during Intensive Care Unit Procedures.

Beesley SJ, Hopkins RO, Francis L, Chapman D, Johnson J, Johnson N, Brown SM.

Ann Am Thorac Soc. 2016 Jul;13(7):1155-9. doi: 10.1513/AnnalsATS.201511-754OI.

PMID:
27104301
10.

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.

Saunders EJ, Dadaev T, Leongamornlert DA, Al Olama AA, Benlloch S, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pasayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Pandha H, Govindasami K, Muir K; UK Genetic Prostate Cancer Study Collaborators.; UK ProtecT Study Collaborators.; PRACTICAL Consortium., Easton DF, Eeles RA, Kote-Jarai Z.

Br J Cancer. 2016 Apr 12;114(8):945-52.

11.

Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both: The TRAPEZE Randomized Clinical Trial.

James ND, Pirrie SJ, Pope AM, Barton D, Andronis L, Goranitis I, Collins S, Daunton A, McLaren D, O'Sullivan J, Parker C, Porfiri E, Staffurth J, Stanley A, Wylie J, Beesley S, Birtle A, Brown J, Chakraborti P, Hussain S, Russell M, Billingham LJ.

JAMA Oncol. 2016 Apr;2(4):493-9. doi: 10.1001/jamaoncol.2015.5570.

PMID:
26794729
12.

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.

James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Spears MR, Ritchie AW, Parker CC, Russell JM, Attard G, de Bono J, Cross W, Jones RJ, Thalmann G, Amos C, Matheson D, Millman R, Alzouebi M, Beesley S, Birtle AJ, Brock S, Cathomas R, Chakraborti P, Chowdhury S, Cook A, Elliott T, Gale J, Gibbs S, Graham JD, Hetherington J, Hughes R, Laing R, McKinna F, McLaren DB, O'Sullivan JM, Parikh O, Peedell C, Protheroe A, Robinson AJ, Srihari N, Srinivasan R, Staffurth J, Sundar S, Tolan S, Tsang D, Wagstaff J, Parmar MK; STAMPEDE investigators..

Lancet. 2016 Mar 19;387(10024):1163-77. doi: 10.1016/S0140-6736(15)01037-5. Epub 2015 Dec 21.

13.

Why we need a new definition of sepsis.

Beesley SJ, Lanspa MJ.

Ann Transl Med. 2015 Nov;3(19):296. doi: 10.3978/j.issn.2305-5839.2015.11.02.

14.

A tunable artificial circadian clock in clock-defective mice.

D'Alessandro M, Beesley S, Kim JK, Chen R, Abich E, Cheng W, Yi P, Takahashi JS, Lee C.

Nat Commun. 2015 Nov 30;6:8587. doi: 10.1038/ncomms9587.

15.

Calcium channel genes associated with bipolar disorder modulate lithium's amplification of circadian rhythms.

McCarthy MJ, Le Roux MJ, Wei H, Beesley S, Kelsoe JR, Welsh DK.

Neuropharmacology. 2016 Feb;101:439-48. doi: 10.1016/j.neuropharm.2015.10.017. Epub 2015 Oct 22.

16.

The Worldwide End-of-Life Practice for Patients in Intensive Care Units Study: Adding Africa.

Beesley SJ, Siika W, Nyale G, Kituyi P, Kussin P.

Am J Respir Crit Care Med. 2015 Sep 15;192(6):768-9. doi: 10.1164/rccm.201505-1032LE. No abstract available.

PMID:
26371819
17.

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans.

Amin Al Olama A, Dadaev T, Hazelett DJ, Li Q, Leongamornlert D, Saunders EJ, Stephens S, Cieza-Borrella C, Whitmore I, Benlloch Garcia S, Giles GG, Southey MC, Fitzgerald L, Gronberg H, Wiklund F, Aly M, Henderson BE, Schumacher F, Haiman CA, Schleutker J, Wahlfors T, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, Mcdonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokołorczyk D, Kluzniak W, Cannon-Albright L, Brenner H, Butterbach K, Arndt V, Park JY, Sellers T, Lin HY, Slavov C, Kaneva R, Mitev V, Batra J, Clements JA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Govindasami K, Guy M, Lophatonanon A, Muir K, Viñuela A, Brown AA; PRACTICAL Consortium.; COGS-CRUK GWAS-ELLIPSE (Part of GAME-ON) Initiative.; Australian Prostate Cancer BioResource.; UK Genetic Prostate Cancer Study Collaborators.; UK ProtecT Study Collaborators., Freedman M, Conti DV, Easton D, Coetzee GA, Eeles RA, Kote-Jarai Z.

Hum Mol Genet. 2015 Oct 1;24(19):5589-602. doi: 10.1093/hmg/ddv203. Epub 2015 May 29.

18.

Circadian clock regulation of melatonin MTNR1B receptor expression in human myometrial smooth muscle cells.

Beesley S, Lee J, Olcese J.

Mol Hum Reprod. 2015 Aug;21(8):662-71. doi: 10.1093/molehr/gav023. Epub 2015 May 4.

PMID:
25939854
19.

Clinical significance of melatonin receptors in the human myometrium.

Olcese J, Beesley S.

Fertil Steril. 2014 Aug;102(2):329-35. doi: 10.1016/j.fertnstert.2014.06.020. Epub 2014 Jul 9. Review.

PMID:
25015556
20.

Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk.

Dunlop MG, Dobbins SE, Farrington SM, Jones AM, Palles C, Whiffin N, Tenesa A, Spain S, Broderick P, Ooi LY, Domingo E, Smillie C, Henrion M, Frampton M, Martin L, Grimes G, Gorman M, Semple C, Ma YP, Barclay E, Prendergast J, Cazier JB, Olver B, Penegar S, Lubbe S, Chander I, Carvajal-Carmona LG, Ballereau S, Lloyd A, Vijayakrishnan J, Zgaga L, Rudan I, Theodoratou E; Colorectal Tumour Gene Identification (CORGI) Consortium., Starr JM, Deary I, Kirac I, Kovacević D, Aaltonen LA, Renkonen-Sinisalo L, Mecklin JP, Matsuda K, Nakamura Y, Okada Y, Gallinger S, Duggan DJ, Conti D, Newcomb P, Hopper J, Jenkins MA, Schumacher F, Casey G, Easton D, Shah M, Pharoah P, Lindblom A, Liu T; Swedish Low-Risk Colorectal Cancer Study Group., Smith CG, West H, Cheadle JP; COIN Collaborative Group., Midgley R, Kerr DJ, Campbell H, Tomlinson IP, Houlston RS.

Nat Genet. 2012 May 27;44(7):770-6. doi: 10.1038/ng.2293.

Supplemental Content

Loading ...
Support Center